1 years treating Myeloma

350 Myeloma patients anually

clinical research in active and relapsed refractory multiple myeloma disease. I am a principal investigator in clinical trials within the Alliance for Clinical Trials, investigator-initiated and investigator sponsored trials. My area of interest in clinical trials includes use of immunotherapies and targeted therapies, such as bispecific/tri-specific antibodies, antibody-drug conjugates and modern immune modulating drugs (ex. cereblon modulators). Additionally, I’m working on therapeutic advancement of minority populations and enhanced inclusion of these patients in clinical trials to allow for real world representative diversity and true equity in the treatment of all patients with multiple myeloma.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811